Stay updated with breaking news from Solid Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), will host...
The U.S. Food and Drug Administration cleared a shortened version of a gene for a muscle protein to be used in 4- and 5-year-olds with muscular dystrophy.
If Sarepta's gene therapy SRP-9001 succeeded through this accelerated approval pathway, then many more can as well.
New York, June 15, 2023 (GLOBE NEWSWIRE) -- June 15, 2023 -- CureDuchenne, Muscular Dystrophy Association (MDA), and Parent Project Muscular Dystrophy...
Finepoint Capital LP acquired a new position in Solid Biosciences Inc. (NASDAQ:SLDB – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 218,562 shares of the company’s stock, valued at approximately $1,176,000. Solid Biosciences makes up approximately 0.4% of Finepoint Capital […]